204 related articles for article (PubMed ID: 34269492)
1. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
[TBL] [Abstract][Full Text] [Related]
3. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
[TBL] [Abstract][Full Text] [Related]
4. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
Delerue C; Pasquier D; Bogart E; Mirabel X; Laffarguette J; Lals S; Barthoulot M; Lartigau E; Liem X
Radiother Oncol; 2024 Jan; 190():110029. PubMed ID: 38007041
[TBL] [Abstract][Full Text] [Related]
7. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
Kinj R; Doyen J; Hannoun-Lévi JM; Naghavi AO; Chand ME; Baudin G; Ferrero JM; François E; Evesque L; Borchiellini D; Benezery K; Bondiau PY
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e15-e21. PubMed ID: 32641243
[TBL] [Abstract][Full Text] [Related]
9. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
10. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation of head and neck cancer using modern highly conformal techniques.
Ho JC; Phan J
Head Neck; 2018 Sep; 40(9):2078-2093. PubMed ID: 29684256
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
Strom T; Wishka C; Caudell JJ
Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
[TBL] [Abstract][Full Text] [Related]
18. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
19. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
[TBL] [Abstract][Full Text] [Related]
20. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
